SCHEMBL29322340

SCHEMBL29322340

COc1ccc(CN(Cc2ccc(OC)cc2)c2cc(Br)c(C(F)(F)F)cn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
DRD1 P21728 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
SLC6A4 P31645 1/20 0.40
CYP2C19 P33261 1/20 0.40
HRH1 P35367 1/20 0.40
OPRM1 P35372 1/20 0.40
HTR2B P41595 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23913687 0.90 LMNA (0.40) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL26694776 0.86 LMNA (0.41) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL29999653 0.86 LMNA (0.41) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL23915537 0.82 PDK1 (0.41) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL15464283 0.81 LMNA (0.43) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL25886269 0.81 LMNA (0.43) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL30873380 0.81 LMNA (0.43) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL30484810 0.81 LMNA (0.43) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL30710039 0.79 QPCT (0.42) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL26694781 0.79 QPCT (0.42) LMNAMAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228512-A1 ACYCLIC OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF GENENTECH, INC. (US) 2024-07-11 US disclosed
US-20240228512-A1 ACYCLIC OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF GENENTECH, INC. (US) 2024-07-11 US disclosed
WO-2024083168-A1 OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF GENENTECH, INC. (US) 2024-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228512-A1 ACYCLIC OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF AZI2, HDAC5, HDAC4 LMNA 4375/4885MAPT 3890/4885MEN1 3341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.